#None #ALR Technologies #GluCurve #Diabetic Monitoring

ALR Technologies to Relaunch the GluCurve Pet CGM

ALR Technologies SG Ltd, known as ALRT, is gearing up for the relaunch of its GluCurve Pet Continuous Glucose Monitor (CGM) in January 2026. This innovative device, designed specifically for cats and dogs, is making significant strides in the veterinary diabetes management space.

The completion of internal manufacturing testing has shown that the GluCurve delivers precision in blood glucose readings comparable to the leading veterinary blood glucose meters (BGM). This groundbreaking product aims to simplify diabetes monitoring for pets, offering a sustainable solution for the increasing number of households with diabetic dogs and cats.

What is GluCurve?

The GluCurve is the first CGM specifically tailored for veterinary use. This device utilizes a pet-friendly sensor that attaches painlessly to a pet's body, providing real-time blood sugar readings every three minutes for up to 14 days. Pet owners can track their furry friends' glucose levels using the GluCurve app, which directly uploads data to the ALRT Veterinary Web Portal. This seamless integration allows veterinarians to monitor conditions and adjust insulin dosages efficiently, whether they're in the clinic or communicating remotely with pet owners.

Joe Stern, the Head of Animal Health at ALRT, remarked on the considerable demand for the GluCurve Pet CGM. He noted that there are an estimated 150,000 to 300,000 potential units per year in Canada alone, with even more explosive potential in the United States and Europe. This demand underscores the pressing need for reliable diabetes management tools in veterinary medicine, as traditional methods like finger pricking are impractical for pets.

Collaboration and Manufacturing

ALR Technologies is excited to partner with CGM Medical Technology Shenzhen Ltd. for the manufacturing of their CGM units. The collaboration has led to enhancements in manufacturing capabilities at the Foxconn facility in Shenzhen, driving the project towards its long-awaited launch. After two years of rigorous development, the refined GluCurve Pet CGM is now on the horizon, eagerly anticipated by veterinarians and pet owners alike.

Upcoming independent studies are set to validate the GluCurve's performance against the top BGM products used in practice today, further boosting confidence in this revolutionary product. Initial feedback indicates that the integration of the GluCurve into routine diabetes care for pets could transform how veterinarians approach insulin dosages and overall diabetes management.

Launch Plans and Availability

Upon relaunch, veterinary clinics in Canada will be able to place direct orders through the official Canadian website, www.GluCurve.ca. ALRT is also exploring various purchasing group collaborations to ensure widespread availability and access to the device. Following its Canadian debut, a release in the United States is expected in early Q2 2026, backed by a strategic partnership with a leading veterinary distributor. Global aspirations include launches in Europe, Australia, Asia, and South America shortly after.

As interest in the GluCurve continues to grow, the company commits to keeping the public informed regarding its availability and updates on sales, partnerships, and other impactful news.

About ALR Technologies

ALR Technologies SG Ltd is a data management company that focuses on optimizing diabetes care. Their portfolio includes a range of innovative solutions, from FDA-cleared diabetes management systems to their forthcoming GluCurve Pet CGM. By striving to improve treatment outcomes for both humans and pets, they underscore their mission to revolutionize diabetes management across the board.

For further information about GluCurve and other ALRT offerings, please visit their websites at www.alrt.com and www.GluCurve.com in the USA or www.GluCurve.ca in Canada.